DCVC
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Quantum Motion
7 May 2026
Quantum Motion announces its £120m Series C led by DCVC and Kembara to build silicon quantum computers using standard chip manufacturing
Quantum Motion builds quantum computers using silicon transistors manufactured with the same technology as conventional computer chips. Its systems are designed to reduce cost, space and energy use while fitting into standard data centre infrastructure.
Alchemab Therapeutics
9 Sept 2025
Alchemab Therapeutics raises £24m Series A extension led by Ono Venture Investment to advance AI-enabled antibody platform
Alchemab identifies naturally occurring protective antibodies using AI and patient data, developing new therapies based on disease resilience rather than traditional target discovery.
DCVC
- 2(12 months)
- dcvc.com
- Update Information
More venture news
- 9 Jun 2026
PhysicsXPhysicsX announces its £225m Series C led by Temasek to accelerate physics AI for deep tech manufacturing
Series CDeep Tech - 4 Jun 2026
SembleSemble secures £30m Series C led by Revaia to expand its healthcare coordination platform for outpatient providers
Series CHealth - 3 Jun 2026
Oxford Quantum Circuits (OQC)OQC unlocks £260m in a Series C led by Bullhound Capital to deploy superconducting quantum computers in data-centre environments
Series CDeep Tech
